LenioBio GmbH

LenioBio is a life science biotech offering a disruptive protein expression technology. ALiCE is the first eukaryotic cell-free protein expression platform that is scalable and changes the way proteins are produced today, across all industries. ALiCE enables the discovery, development and production of difficult-to-express proteins. Our Head Office in Düsseldorf as well as our Technology & Innovation Center in Aachen are home to our international team who are working on how to have a positive impact on the issues facing the world.